The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Molecular Diagnostics in Infectious Disease Testing-Global Market Insights and Sales Trends 2024
Synopsis
Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others. Increasing number of infectious diseases and technological advancement in diagnostic technologies for infectious diseases are some major driving factors for molecular diagnostics in the infectious disease testing market. Molecular diagnostics technologies are mainly used to diagnose diseases such as AIDS, tuberculosis (TB), hepatitis, and hospital-acquired infections.
The global Molecular Diagnostics in Infectious Disease Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Molecular Diagnostics in Infectious Disease Testing in various end use industries. The expanding demands from the Hospitals, Clinics, Academic Institutes and Laboratories, are propelling Molecular Diagnostics in Infectious Disease Testing market. Polymerase Chain Reaction (PCR), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Isothermal Nucleic Acid Amplification Technology (INAAT) segment is estimated at % CAGR for the next seven-year period.
North America has the largest market for molecular diagnostics in infectious disease testing, followed by Europe. This is due to technological advancement in molecular diagnostic tools, increasing prevalence of infectious diseases and improved healthcare infrastructure in the region. The market in Asia too, is expected to witness a high growth rate in the next few years. This is due to evolving research and development activities on infectious diseases, increasing government support, growing awareness among people about various infectious diseases and their diagnostic procedures, and improving healthcare infrastructure in the region. In addition, growing population and economies in developing countries, such as India and China, are expected to influence the growth in molecular diagnostics in infectious disease testing in Asia.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Molecular Diagnostics in Infectious Disease Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Molecular Diagnostics in Infectious Disease Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Molecular Diagnostics in Infectious Disease Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Molecular Diagnostics in Infectious Disease Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Molecular Diagnostics in Infectious Disease Testing covered in this report include Abbott, BD, BioMerieux, Thermo Fisher Scientific, Roche, Siemens, Veridex, Luminex and GenMark Diagnostics, etc.
The global Molecular Diagnostics in Infectious Disease Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
BD
BioMerieux
Thermo Fisher Scientific
Roche
Siemens
Veridex
Luminex
GenMark Diagnostics
Qiagen
Genomix Biotech
BioTheranostics
Global Molecular Diagnostics in Infectious Disease Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Molecular Diagnostics in Infectious Disease Testing market, Segment by Type:
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Microarrays
Next-Generation Sequencing (NGS)
Hybridization
Others
Global Molecular Diagnostics in Infectious Disease Testing market, by Application
Hospitals
Clinics
Academic Institutes
Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Molecular Diagnostics in Infectious Disease Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others. Increasing number of infectious diseases and technological advancement in diagnostic technologies for infectious diseases are some major driving factors for molecular diagnostics in the infectious disease testing market. Molecular diagnostics technologies are mainly used to diagnose diseases such as AIDS, tuberculosis (TB), hepatitis, and hospital-acquired infections.
The global Molecular Diagnostics in Infectious Disease Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Molecular Diagnostics in Infectious Disease Testing in various end use industries. The expanding demands from the Hospitals, Clinics, Academic Institutes and Laboratories, are propelling Molecular Diagnostics in Infectious Disease Testing market. Polymerase Chain Reaction (PCR), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Isothermal Nucleic Acid Amplification Technology (INAAT) segment is estimated at % CAGR for the next seven-year period.
North America has the largest market for molecular diagnostics in infectious disease testing, followed by Europe. This is due to technological advancement in molecular diagnostic tools, increasing prevalence of infectious diseases and improved healthcare infrastructure in the region. The market in Asia too, is expected to witness a high growth rate in the next few years. This is due to evolving research and development activities on infectious diseases, increasing government support, growing awareness among people about various infectious diseases and their diagnostic procedures, and improving healthcare infrastructure in the region. In addition, growing population and economies in developing countries, such as India and China, are expected to influence the growth in molecular diagnostics in infectious disease testing in Asia.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Molecular Diagnostics in Infectious Disease Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Molecular Diagnostics in Infectious Disease Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Molecular Diagnostics in Infectious Disease Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Molecular Diagnostics in Infectious Disease Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Molecular Diagnostics in Infectious Disease Testing covered in this report include Abbott, BD, BioMerieux, Thermo Fisher Scientific, Roche, Siemens, Veridex, Luminex and GenMark Diagnostics, etc.
The global Molecular Diagnostics in Infectious Disease Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
BD
BioMerieux
Thermo Fisher Scientific
Roche
Siemens
Veridex
Luminex
GenMark Diagnostics
Qiagen
Genomix Biotech
BioTheranostics
Global Molecular Diagnostics in Infectious Disease Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Molecular Diagnostics in Infectious Disease Testing market, Segment by Type:
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Microarrays
Next-Generation Sequencing (NGS)
Hybridization
Others
Global Molecular Diagnostics in Infectious Disease Testing market, by Application
Hospitals
Clinics
Academic Institutes
Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Molecular Diagnostics in Infectious Disease Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Molecular Diagnostics in Infectious Disease Testing
1.1 Molecular Diagnostics in Infectious Disease Testing Market Overview
1.1.1 Molecular Diagnostics in Infectious Disease Testing Product Scope
1.1.2 Molecular Diagnostics in Infectious Disease Testing Market Status and Outlook
1.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2018-2029)
1.4 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Region (2018-2023)
1.5 Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Molecular Diagnostics in Infectious Disease Testing Market Size (2018-2029)
1.6.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size (2018-2029)
1.6.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size (2018-2029)
1.6.4 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size (2018-2029)
2 Molecular Diagnostics in Infectious Disease Testing Market by Type
2.1 Introduction
2.1.1 Polymerase Chain Reaction (PCR)
2.1.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
2.1.3 Microarrays
2.1.4 Next-Generation Sequencing (NGS)
2.1.5 Hybridization
2.1.6 Others
2.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Molecular Diagnostics in Infectious Disease Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Molecular Diagnostics in Infectious Disease Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Molecular Diagnostics in Infectious Disease Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue Breakdown by Type (2018-2029)
3 Molecular Diagnostics in Infectious Disease Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Academic Institutes
3.1.4 Laboratories
3.1.5 Others
3.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Molecular Diagnostics in Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Molecular Diagnostics in Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Molecular Diagnostics in Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
4 Molecular Diagnostics in Infectious Disease Testing Competition Analysis by Players
4.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2022)
4.3 Date of Key Players Enter into Molecular Diagnostics in Infectious Disease Testing Market
4.4 Global Top Players Molecular Diagnostics in Infectious Disease Testing Headquarters and Area Served
4.5 Key Players Molecular Diagnostics in Infectious Disease Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Molecular Diagnostics in Infectious Disease Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.1.4 Abbott Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 BD
5.2.1 BD Profile
5.2.2 BD Main Business
5.2.3 BD Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.2.4 BD Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.2.5 BD Recent Developments
5.3 BioMerieux
5.3.1 BioMerieux Profile
5.3.2 BioMerieux Main Business
5.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.3.4 BioMerieux Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Thermo Fisher Scientific Recent Developments
5.4 Thermo Fisher Scientific
5.4.1 Thermo Fisher Scientific Profile
5.4.2 Thermo Fisher Scientific Main Business
5.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.4.4 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Thermo Fisher Scientific Recent Developments
5.5 Roche
5.5.1 Roche Profile
5.5.2 Roche Main Business
5.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.5.4 Roche Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Roche Recent Developments
5.6 Siemens
5.6.1 Siemens Profile
5.6.2 Siemens Main Business
5.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.6.4 Siemens Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Siemens Recent Developments
5.7 Veridex
5.7.1 Veridex Profile
5.7.2 Veridex Main Business
5.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.7.4 Veridex Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Veridex Recent Developments
5.8 Luminex
5.8.1 Luminex Profile
5.8.2 Luminex Main Business
5.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.8.4 Luminex Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Luminex Recent Developments
5.9 GenMark Diagnostics
5.9.1 GenMark Diagnostics Profile
5.9.2 GenMark Diagnostics Main Business
5.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.9.4 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.9.5 GenMark Diagnostics Recent Developments
5.10 Qiagen
5.10.1 Qiagen Profile
5.10.2 Qiagen Main Business
5.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.10.4 Qiagen Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Qiagen Recent Developments
5.11 Genomix Biotech
5.11.1 Genomix Biotech Profile
5.11.2 Genomix Biotech Main Business
5.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.11.4 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Genomix Biotech Recent Developments
5.12 BioTheranostics
5.12.1 BioTheranostics Profile
5.12.2 BioTheranostics Main Business
5.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Products, Services and Solutions
5.12.4 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.12.5 BioTheranostics Recent Developments
6 North America
6.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Molecular Diagnostics in Infectious Disease Testing Market Dynamics
11.1 Molecular Diagnostics in Infectious Disease Testing Industry Trends
11.2 Molecular Diagnostics in Infectious Disease Testing Market Drivers
11.3 Molecular Diagnostics in Infectious Disease Testing Market Challenges
11.4 Molecular Diagnostics in Infectious Disease Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
